ACC/AHA Clinical Data Standards
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)

https://doi.org/10.1016/j.jacc.2014.12.018Get rights and content
Under an Elsevier user license
open archive

Key Words

ACC Data Standards
cardiovascular endpoints
clinical events
clinical trials
death
heart failure
myocardial infarction
percutaneous coronary intervention
peripheral vascular intervention
stroke
unstable angina

Cited by (0)

This document was approved by the American Heart Association Science Advisory and Coordinating Committee on June 13, 2014, and by the American College of Cardiology Board of Trustees on November 12, 2014.

The American College of Cardiology requests that this document be cited as follows: Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Am Coll Cardiol 2015;66:403-69.

This article has been copublished in Circulation.

Copies: This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org) and the American Heart Association (my.americanheart.org). For copies of this document, please contact the Elsevier Inc. Reprints Department via fax (212) 633-3820 or e-mail [email protected].

Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American College of Cardiology. Requests may be completed online via the Elsevier site (http://www.elsevier.com/about/policies/author-agreement/obtaining-permission).

The findings and conclusions in this report are those of the authors and do not necessarily represent the official positions of the U.S. Food and Drug Administration.